Log in to your Inderes Free account to see all free content on this page.
Linc
100.8 SEK +4.13%Be the first to follow this company
Linc is an investment company. The company specializes in investment, ownership, and further management of companies in the Life Science industry. The investments are mainly made in small and medium-sized product-oriented life science companies in medical technology and pharmaceuticals. The vision is to be an active and long-term owner. The largest share of investments takes place in the Nordic region.
Revenue
-
EBIT %
-
P/E
9.42
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
LINC
Daily low / high price
96.8 / 100.8
SEK
Market cap
5.84B SEK
Turnover
1.99M SEK
Volume
20K
Financial calendar
Interim report
24.10.2024
Annual report
23.01.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Bengt Julander | 57.2 % | 57.2 % |
Nordea fonder | 5.1 % | 5.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Offering price for Linc’s initial public offering set at SEK 67 per share – trading on Nasdaq Stockholm commences tomorrow
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio